Stratification by cancer type showed that the NFKB1 -94ins/delATTG polymorphism was inversely associated with the risk of lung cancer, nasopharyngeal carcinoma, prostate cancer, ovarian cancer, and oral squamous cell carcinoma, but no association was found for hepatocellular carcinoma, colorectal cancer, bladder cancer, gastric cancer, cervical cancer, breast cancer, or other cancers. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.